Amarin Corp Plc (AMRN)

[sstyles]

The FDA meeting today from the WSJ:

Multiple members of the committee also voiced concerns over the limited data so far about whether a third dose increases the risk of myocarditis, an inflammatory heart condition that has so far been found to be a rare side effect primarily in young men. FDA officials told panel members that the risk of the condition is unknown so far, and that more research needed to be done.